Eugene Ruby1, Karen Rothman1, Cheryl Corcoran2, Raymond R Goetz1,2, Dolores Malaspina1,3. 1. Department of Psychiatry, New York University School of Medicine, Institute for Social and Psychiatric Initiatives-Research, Education, and Services (InSPIRES), New York, New York, USA. 2. Department of Psychiatry, New York State Psychiatric Institute, Columbia University, New York, New York, USA. 3. Creedmoor Psychiatric Center, New York State Office of Mental Health, New York, New York, USA.
Abstract
AIM: This proof-of-concept study examined if early trauma influences features of schizophrenia, consistent with hypothalamic-pituitary-adrenal (HPA) axis activation. METHODS: Early trauma and current perceived stress were assessed in 28 treated schizophrenia cases, along with salivary cortisol, brain volumes, cognition and symptoms. RESULTS: Early trauma predicted more positive (r = .66, P = .005) and dysthymia symptoms (r -.65, P = .007), but less negative symptoms (r = -.56, P = .023), as well as reduced whole brain volumes (r = .50, P = .040) and increased amygdala to whole brain volume ratios (r = .56, P = .018). Larger volume reductions accompanied cortisol levels: evening values predicted smaller whole brain and hippocampal volumes whereas afternoon levels only significantly predicted smaller brain volumes in women. Sex differences were demonstrated between early trauma and cognition, with better cognition in traumatized women than other women and no male effects. Current perceived stress was related to dysthymia (especially in women) and diminished sense of purpose and social drive (especially in men). CONCLUSIONS: These results suggest that early trauma and current stress impact features of schizophrenia, consistent with stress sensitization and increased dopamine activity for treatment refractory positive symptoms, as well as the cascade of increased morning cortisol, reduced brain volumes, and depressive and deficit symptoms. Conversely, cognitive deficits and negative symptoms may arise from a distinct diathesis. The sex differences accord with the literature on human HPA function and stress responses. Early trauma may be a stressor in the aetiopathophysiology of schizophrenia, particularly for cases with treatment refractory positive symptoms, and may guide future treatment development.
AIM: This proof-of-concept study examined if early trauma influences features of schizophrenia, consistent with hypothalamic-pituitary-adrenal (HPA) axis activation. METHODS: Early trauma and current perceived stress were assessed in 28 treated schizophrenia cases, along with salivary cortisol, brain volumes, cognition and symptoms. RESULTS: Early trauma predicted more positive (r = .66, P = .005) and dysthymia symptoms (r -.65, P = .007), but less negative symptoms (r = -.56, P = .023), as well as reduced whole brain volumes (r = .50, P = .040) and increased amygdala to whole brain volume ratios (r = .56, P = .018). Larger volume reductions accompanied cortisol levels: evening values predicted smaller whole brain and hippocampal volumes whereas afternoon levels only significantly predicted smaller brain volumes in women. Sex differences were demonstrated between early trauma and cognition, with better cognition in traumatized women than other women and no male effects. Current perceived stress was related to dysthymia (especially in women) and diminished sense of purpose and social drive (especially in men). CONCLUSIONS: These results suggest that early trauma and current stress impact features of schizophrenia, consistent with stress sensitization and increased dopamine activity for treatment refractory positive symptoms, as well as the cascade of increased morning cortisol, reduced brain volumes, and depressive and deficit symptoms. Conversely, cognitive deficits and negative symptoms may arise from a distinct diathesis. The sex differences accord with the literature on human HPA function and stress responses. Early trauma may be a stressor in the aetiopathophysiology of schizophrenia, particularly for cases with treatment refractory positive symptoms, and may guide future treatment development.
Authors: S L Rauch; B A van der Kolk; R E Fisler; N M Alpert; S P Orr; C R Savage; A J Fischman; M A Jenike; R K Pitman Journal: Arch Gen Psychiatry Date: 1996-05
Authors: Valeria Mondelli; Paola Dazzan; Nilay Hepgul; Marta Di Forti; Monica Aas; Alessandro D'Albenzio; Marco Di Nicola; Helen Fisher; Rowena Handley; Tiago Reis Marques; Craig Morgan; Serena Navari; Heather Taylor; Andrew Papadopoulos; Katherine J Aitchison; Robin M Murray; Carmine M Pariante Journal: Schizophr Res Date: 2009-09-13 Impact factor: 4.939
Authors: Michael P Gardner; Stafford Lightman; Avan Aihie Sayer; Cyrus Cooper; Rachel Cooper; Dorly Deeg; Shah Ebrahim; John Gallacher; Mika Kivimaki; Meena Kumari; Diana Kuh; Richard M Martin; Geeske Peeters; Yoav Ben-Shlomo Journal: Psychoneuroendocrinology Date: 2012-05-31 Impact factor: 4.905
Authors: Gabriella Riley; Mary Perrin; Leila M Vaez-Azizi; Eugene Ruby; Raymond R Goetz; Roberta Dracxler; Julie Walsh-Messinger; David L Keefe; Peter F Buckley; Philip R Szeszko; Dolores Malaspina Journal: Schizophr Res Date: 2018-04-02 Impact factor: 4.939
Authors: Nikolaos P Daskalakis; Edo Ronald De Kloet; Rachel Yehuda; Dolores Malaspina; Thorsten M Kranz Journal: Front Mol Neurosci Date: 2015-11-16 Impact factor: 5.639
Authors: Deanna L Kelly; Laura M Rowland; Kathleen M Patchan; Kelli Sullivan; Amber Earl; Heather Raley; Fang Liu; Stephanie Feldman; Robert P McMahon Journal: Child Adolesc Psychiatry Ment Health Date: 2016-03-03 Impact factor: 3.033